FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/12/099699 [Registered on: 23/12/2025] Trial Registered Prospectively
Last Modified On: 22/12/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A study comparing how well regular ultrasound therapy works versus ultrasound combined with a special pain-relief gel for treating muscle pain problem. 
Scientific Title of Study   Comparative efficacy of Therapeutic Ultrasound versus Phonophoresis with Permeation-Enhanced Diclofenac-Tizanidine Gel in Myofascial Pain Dysfunction Syndrome:A Randomized Controlled Clinical Study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sakshi Ramswarup Somani 
Designation  Junior Resident 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Dept.of Oral Medicine and Radiology Sharad Pawar Dental College building ground floor, Sawangi Meghe.

Wardha
MAHARASHTRA
442001
India 
Phone  09561479017  
Fax    
Email  sakshisomani09@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrSuwarna Dangore 
Designation  Professor and Head 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Dept.of Oral Medicine and Radiology Sharad Pawar Dental College building ground floor, Sawangi Meghe.

Wardha
MAHARASHTRA
442001
India 
Phone  9923024036  
Fax    
Email  dangore_suwarna@rediffmail.com   
 
Details of Contact Person
Public Query
 
Name  DrSuwarna Dangore 
Designation  Professor and Head 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Dept.of Oral Medicine and Radiology Sharad Pawar Dental College building ground floor, Sawangi Meghe.

Wardha
MAHARASHTRA
442001
India 
Phone  9923024036  
Fax    
Email  dangore_suwarna@rediffmail.com   
 
Source of Monetary or Material Support  
Datta Meghe Institute of Higher Education and Research, Sawangi Meghe, Wardha, Maharashtra, India 442001 
 
Primary Sponsor  
Name  Datta Meghe Institute of Higher Education and Research 
Address  Sawangi Meghe, Wardha, Maharashtra, India 442001 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Nil 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sakshi Somani  Sharad Pawar Dental College  Dept. of Oral Medicine and Radiology, Ground Floor, SPDC Building, Sawangi Meghe
Wardha
MAHARASHTRA 
9561479017

sakshisomani09@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Datta Meghe Institute of Higher Education and Research, Wardha  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M629||Disorder of muscle, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Phonophoresis with Permeation Enhanced Diclofenac Tizanidine gel  Therapeutic ultrasound used to facilitate delivery of diclofenac tizanidine gel to affected myofascial region in patients with myofascial pain dysfunction syndrome  
Comparator Agent  Therapeutic Ultrasound alone  Conventional therapeutic ultrasound applied to the affected myofascial region without any topical drug application. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1. Pain in preauricular region
2. Pain on palpation of masticatory muscles
3. Presence of joint sounds clicking
4. Restricted mouth opening
5. No clinical, radiographic or biochemical evidence of organic joint disease
 
 
ExclusionCriteria 
Details  1.Pregnant or lactating women
2.Patient with pacemakers
3.Known Allergy to Diclofenac Tizanidine
4.Pain of Odontogenic origin
5.Neuralgia or neuromuscular disorder
6.Currently on anti-inflammatory, muscle relaxants analgesic medication
7.Intra-articular TMJ disorders
8.Jaw tumors
9.History of trauma 
 
Method of Generating Random Sequence   Adaptive randomization, such as minimization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Pain Intensity measured using Visual analog scale  2 weeks interval 
 
Secondary Outcome  
Outcome  TimePoints 
Maximum mouth opening measured using Jaw Functional Limitation Scale  2 weeks interval 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   15/02/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Background: Myofascial Pain Dysfunction Syndrome (MPDS) is a common musculoskeletal condition characterized by muscle pain, trigger points, and functional limitation. Physical therapy modalities such as therapeutic ultrasound and phonophoresis are widely used to relieve pain and inflammation. However, evidence comparing their relative efficacy, especially with permeation-enhanced diclofenac–tizanidine gel, remains limited, warranting comparative clinical evaluation.
Aims: To compare the efficacy of therapeutic ultrasound versus phonophoresis with permeation-enhanced diclofenac–tizanidine gel in reducing pain and improving function in patients with Myofascial Pain Dysfunction Syndrome.
Methodology: A randomized parallel-group active-controlled clinical trial was conducted on patients diagnosed with Myofascial Pain Dysfunction Syndrome. Participants were randomly allocated to receive either therapeutic ultrasound or phonophoresis with permeation-enhanced diclofenac–tizanidine gel. Pain intensity and functional outcomes were assessed pre- and post-intervention using standardized clinical scales.
 
Close